Tuyo Health sits at No. 207 in our ranking with a Brief Score of 68. Here are the GLP-1 providers we'd weigh against it — ranked on the same six-factor Brief Score, top down.
Prefer a straight head-to-head? CoreAge Rx vs Tuyo Health.
One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.
A rare accredited provider that pairs brand-name access with fair mid-market compounded pricing across all 50 states.
One of the few accredited providers pairing compounded pricing with brand-name access, nationwide.
A longevity-leaning brand with one of the lowest tracked semaglutide stickers — but a thin disclosure on the rest.
FitRx offers brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) with insurance coordination as low as $25/month, plus compounded semaglutide from $151/month without insurance.
FDA warning letter, February 2026 — issued to FitRX, LLC dba FitRx. See the FDA's warning letter database.
TrueMe is a cash-pay telehealth brand offering compounded semaglutide and tirzepatide with added B vitamins, alongside NAD+, sermorelin and glutathione.
Established virtual primary-care telehealth platform (subsidiary of Transcarent, Inc., a Delaware corporation, alongside Accolade, 2nd.MD, and 98point6 by Transcarent).
A nationwide women's provider (Gala GLP-1, from AI Coaching Inc) whose cheap compounded-tirzepatide door only opens on a yearly subscription — with, unusually, a brand-name path on the shelf beside it.
Cielo is a compounded-GLP-1-only telehealth platform offering semaglutide and tirzepatide with no brand-name drugs and no TRT, hair, or mental-health add-ons — a focused.
On the record
The FDA issued a warning letter to Tuyo Health, Inc. dba Tuyo Health in September 2025. Tuyo Health keeps its place here and its link is unchanged — but you should know the letter exists before you start care. Read it in the FDA's warning letter database.
Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.